Carmex

Specright Recognized as a Representative Vendor in New GartnerĀ® Market Guide for Packaging and Product Specification Management; Company also Shares 2022 Business Momentum Milestones

Retrieved on: 
Thursday, November 17, 2022

TUSTIN, Calif., Nov. 17, 2022 /PRNewswire/ -- Specright, Inc., the pioneer of Specification Management software that helps customers take control of their supply chain data, today shared business momentum milestones from this year that cement its position as category leader, including new recognition from Gartner. The 2022 Gartner Market Guide for Packaging and Product Specification Management names Specright as a Representative Vendor for Packaging and Product Specification Management (PPSM).

Key Points: 
  • The 2022 Gartner Market Guide for Packaging and Product Specification Management names Specright as a Representative Vendor for Packaging and Product Specification Management (PPSM).
  • "It's rewarding for the entire Specright team to reap the recognition of our industry-leading position in the market."
  • Digitized Specification Management is vital for businesses in packaging, product development, supply chain, manufacturing, and more that need to easily create, share, and track product and packaging specifications while working closely with suppliers to bring their product to market while ensuring sustainability.
  • Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact.

Kingworld Medicines Sees 2021 Profit Soar 159% to RMB30.3 Million

Retrieved on: 
Tuesday, March 29, 2022

Although the Group faced many uncertainties in 2021, it managed to achieve a significant recovery and growth.

Key Points: 
  • Although the Group faced many uncertainties in 2021, it managed to achieve a significant recovery and growth.
  • Profit attributable to owners of the Company increased by 159% to approximately RMB30.3 million.
  • The Board recommends the payment of a final dividend of HK2.39 cents per share for the year ended 31 December 2021 (2020: HK0.65 cents).
  • In respect of pharmaceutical product distribution business, the Group continued to optimize its channel network layout and made structural adjustments.